Quarterly report [Sections 13 or 15(d)]

Summary of Significant Accounting Policies - Schedule of Dilutive Securities Excluded from Diluted Net Loss Per Share (Details)

v3.26.1
Summary of Significant Accounting Policies - Schedule of Dilutive Securities Excluded from Diluted Net Loss Per Share (Details) - shares
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Schedule of Dilutive Securities Excluded from Diluted Net Loss Per Share [Line Items]    
Total potentially dilutive securities 305,637,672 128,280,346
Warrants to purchase common stock [Member]    
Schedule of Dilutive Securities Excluded from Diluted Net Loss Per Share [Line Items]    
Total potentially dilutive securities 195,527,101 25,384,610
Options to purchase common stock [Member]    
Schedule of Dilutive Securities Excluded from Diluted Net Loss Per Share [Line Items]    
Total potentially dilutive securities 654,350 9,349,311
Contingently issuable shares [Member]    
Schedule of Dilutive Securities Excluded from Diluted Net Loss Per Share [Line Items]    
Total potentially dilutive securities 109,456,221
Potential shares issuable under 2022 Convertible Promissory Notes [Member]    
Schedule of Dilutive Securities Excluded from Diluted Net Loss Per Share [Line Items]    
Total potentially dilutive securities 19,502,416
Potential shares issuable under 2023 Additional Notes [Member]    
Schedule of Dilutive Securities Excluded from Diluted Net Loss Per Share [Line Items]    
Total potentially dilutive securities 30,237,267
Potential shares issuable under 2024 Additional Notes [Member]    
Schedule of Dilutive Securities Excluded from Diluted Net Loss Per Share [Line Items]    
Total potentially dilutive securities 42,348,142
Restricted stock units [Member]    
Schedule of Dilutive Securities Excluded from Diluted Net Loss Per Share [Line Items]    
Total potentially dilutive securities 1,458,600